[The Diagnostic Application of Bedside Measurement of Plasma Brain Natriuretic in Patients with Heart Failure].

Le-wen Shao,Yang Han,Zhan-kun Wang,Jian Sun
DOI: https://doi.org/10.3760/j.issn:0578-1426.2005.02.007
2005-01-01
Abstract:OBJECTIVE:To investigate differential diagnoses value of ultra-rapid bedside measurement of brain natriuretic peptide (BNP) in patients with dyspnea. METHODS:Plasma BNP concentration were measured with immunofluorescence assay in 103 patients with dyspnea. Left ventricular ejection fraction (LVEF) and pulmonary capillary wedge pressure (PCWP) were determined by echocardiography and Swan-Ganz catheter in these patients on the same time, respectively. RESULTS:(1) Plasma BNP levels in the patients with heart failure were higher than those in the non-heart failure patients [(716 +/- 86 vs 46 +/- 7) ng/L, P < 0.01]. (2) The sensitivity, specificity and negative predictive values of Plasma BNP levels > or = 100 pg/ml for predicting heart failure were 95.2% (60/63), 93.0% (40/43) and 97.1% (100/103), respectively. (3) Plasma BNP levels were positively related to PCWP, and negatively related to LVEF (r = -0.56, both P < 0.01). CONCLUSION:Bedside BNP assay is sensitive and specific for diagnosing heart failure, and is useful in evaluating dyspnea in emergency care.
What problem does this paper attempt to address?